TY  - JOUR
AU  - Prentice, RE
AU  - Tjandra, D
AU  - Garg, M
AU  - Lubel, JS
AU  - Fourlanos, S
AU  - Johnson, D
AU  - Al-Ani, A
AU  - Christensen, B
Y2  - 2020/12/16
Y1  - 2020/10
SN  - 0269-2813
UR  - http://hdl.handle.net/11343/254607
LA  - eng
T1  - Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
DO  - 10.1111/apt.16063
IS  - Alimentary Pharmacology and Therapeutics
VL  - 52
IS  - 8
SP  - 1422-1423
ER  -